REPIGMENTATION: Treatment of vitiligo lesions by ReNovaCell® vs conventional melanocyte-keratinocyte transplantation(MKT): a pilot study.
Within-subject comparative study (n=5, MKT vs RES™). Comparable pigmentation was observed between RES™ and MKT, but without specialised laboratory facilities.
REPIGMENTATION: Evaluation for performance of ReNovaCell® for repigmentation.
RES™+ CO2 laser with UVA within-subject pilot RCT (n=10) for patients with stable segmental vitiligo. Median re-pigmentation was 78% for RES™ treated areas, 0% for CO2 control or no treatment areas.
SCAR REVISION: Combination of Medical Needling and ReNovaCell® for Repigmentation of Hypopigmented Burn Scars.
Patients with 1 year old hypopigmented scars treated with RES™ (n=20). The combination of medical needling and RES™ resulted in statistically significant objectively measured repigmentation vs within-subject control scar.
SCAR REVISION: Use of a novel autologous cell-harvesting device to promote epithelialization and enhance appropriate pigmentation in scar reconstruction.
RES™ treatment of post-traumatic scars (n=30) resulted in excellent or good aesthetic and functional outcomes (80%) and normal pigmentation (60%) of the patients.